Clinical Trial Update: Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease [NA]

View source ↗

Summary

A clinical trial update examining the effects of paricalcitol (Zemplar) on endothelial function and inflammation in people with type 2 diabetes and chronic kidn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Zemplar (Paricalcitol)

Snippet

Sponsor: Scott and White Hospital & Clinic | Conditions: Type 2 Diabetes, Chronic Kidney Disease | NA | Status: UNKNOWN